Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice.

Zemek RM, Chin WLoong, Fear VS, et al. "Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice." Nat Commun. 2022;13(1):4895.